Skip to main content

STIFEL FINANCIAL CORP

Position in NTLA — Intellia Therapeutics, Inc.

CIK 720672 ST. LOUIS, MO

Position in NTLA

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$12,982,889
+$4,609,685 QoQ
Shares Held
1,012,706
+8.7% QoQ
Ownership
0.725%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. NTLA ranks #9 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NTLA

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $12,982,889 1,012,706
2025-12-31 $8,373,204 931,391
2025-09-30 $13,444,970 778,516
2025-06-30 $7,363,618 785,034
2025-03-31 $5,614,495 789,662
2024-12-31 $4,637,891 397,761
2024-09-30 $1,944,234 94,610
2024-06-30 $2,047,948 91,508
2024-03-31 $2,313,370 84,092
2023-12-31 $2,089,265 68,523
2023-09-30 $1,574,327 49,789
2023-06-30 $1,769,933 43,402
2023-03-31 $1,147,356 30,785
2022-12-31 $1,059,085 30,355
2022-09-30 $1,414,948 25,285
2022-06-30 $1,255,542 24,257
2022-03-31 $1,320,340 18,169
2021-12-31 $2,338,077 19,774
2021-09-30 $2,699,499 20,123
2021-06-30 $3,778,330 23,336
2021-03-31 $2,290,236 28,537
2020-12-31 $982,464 18,060